Clinical trials · evidence · 4 minutes reading

Clinical trials digest

What is a clinical trial? A plain record of evidence

A clinical trial is a planned study of a medicine, a medical device, or a diagnostic test in people. The protocol says who may join, which visits happen, and which measurements count. The system holds the record. The sponsor signs the conclusion.

Clinical trialsProtocolConsentArchive
← All articles

4 min

Reading time

EU+US

Doctors and sites

1 record

Drug, device, IVD

A trial is a plan, not a slogan

People search for “clinical trials” when a doctor mentions a study, when a new medicine is in the news, or when a diagnostic test is still under evaluation. The legal object is simpler than the headlines. A protocol defines the population, the interventions, the visits, and the endpoints. A sponsor takes responsibility for the study. Sites collect the data. An ethics committee and an authority allow the work to start. A clinical trial management system does not replace any of those roles. It holds the record of what was planned and what was done, so that an inspector, a statistician, and the investigator can read the same story years later.

A trial is a plan, not a slogan

Full article for doctors, investigators, and readers who follow clinical trials.

What the record contains

Four files travel together, even when vendors split them. The protocol and its amendments. The trial master file of essential documents. The electronic data capture of visits, forms, and queries. The safety cases and their clocks. Statistics then run on a locked snapshot of that capture, with a named method and a version. ValidTrials keeps those pieces in one clinical record for drugs, devices, and diagnostics. As a CRO, we configure the study against the protocol. The archive at the end is open formats the sponsor can read without ValidTrials in twenty-five years. That is what “the record of the study” means on this site.

Phases, randomization, and blinding — without the myth

Drug trials are often described as phase I to IV. Device investigations and IVD performance studies do not use those phases the same way. Randomization and blinding exist to protect the comparison, not to hide the participant from their doctor. Informed consent comes before any study procedure. A person can leave. A doctor can withdraw them. Those facts belong in the record as dated events, not as a footnote in a brochure. Readers of this digest get the operational version: visit windows, eligibility, protocol deviations, and why a missing form is a quality problem before it is a statistical one.

Phases, randomization, and blinding — without the myth

Full article for doctors, investigators, and readers who follow clinical trials.

EU and US packages from the same study

A trial that will be read in Europe and in the United States still has one set of participants. CTR 536/2014 and CTIS shape the EU file. IND review and FDA guidance shape the US file. CDISC tabulations, safety reporting, and the protocol language have to serve both. Sponsors who run two databases to feed two authorities pay twice and reconcile forever. ValidTrials is built so the capture is once. The packages differ. The people in the study do not. Nothing in that design is a claim that a product has been validated. Validation of a conclusion is a human signature on a locked analysis, with a method that can be named.

What this newsletter will not do

We will not recruit you into a named study from this page. We will not write medical advice. We will not let the software declare a product clinically validated. We will explain how trials are run, who holds which duty, and how a computerized system should look to a doctor, a monitor, a statistician, and an inspector. If you want the digest, subscribe. If you have a protocol, we will read it. The first conversation is about the study, not a software tour.

What this newsletter will not do

Full article for doctors, investigators, and readers who follow clinical trials.

Read more from the digest.

Subscribe, or bring us the protocol.

The digest is for doctors and trial readers. The study conversation starts with us.